Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.

Mol Ther · 2016

Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach.

Tremblay JP, Iyombe-Engembe JP, Duchêne B, Ouellet DL

Molecular therapy : the journal of the American Society of Gene Therapy, 24(11): 1888-1889 PMID 27916992 DOI 10.1038/mt.2016.191

Abstract

This article has no abstract in PubMed.